2012
DOI: 10.1253/circj.cj-12-0091
|View full text |Cite
|
Sign up to set email alerts
|

Observational Investigation of Thrombolysis With the Tissue-Type Plasminogen Activator Monteplase for Acute Pulmonary Embolism in Japan

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(8 citation statements)
references
References 16 publications
0
8
0
Order By: Relevance
“…Monteplase, a genetic recombinant tissue-type plasminogen activator, is highly effective for acute pulmonary embolism and offers acceptable safety for severe bleeding complications. 6 …”
Section: Discussionmentioning
confidence: 99%
“…Monteplase, a genetic recombinant tissue-type plasminogen activator, is highly effective for acute pulmonary embolism and offers acceptable safety for severe bleeding complications. 6 …”
Section: Discussionmentioning
confidence: 99%
“…Thrombolysis has been studied in these patients and does not yield any benefit on mortality. 18, 19 Thrombolysis decreased the risk of clinical deterioration by 3-fold, but was associated with a 3-fold higher risk of major bleeding. 4,20,21 Therefore, thrombolysis in cases of submassive PE is not recommended despite its potential effect on RV dilatation and function.…”
Section: Discussionmentioning
confidence: 99%
“…Accelerated regimens involving administration of tissue plasminogen activator (t-PA) during a 2-h period are preferable to prolonged infusions of first-generation thrombolytic agents during a 12- to 24-h period [ 34 ]. Compared with the properties of native t-PA, third-generation bioengineered thrombolytic agents (tenecteplase and monteplase) have a longer half-life, greater clot sensitivity, and more rapid lytic capacity [ 19 , 35 , 36 ]. Monteplase has been approved for acute PE with hemodynamic instability in Japan [ 35 , 36 ].…”
Section: Treatmentmentioning
confidence: 99%